Novolin R
Alternative Names: Humulin, Novolin, Insuman
Novolin R is a short-acting insulin used to help manage blood glucose levels in people with type 1 diabetes. It typically starts working within 30 minutes, peaks around 2–4 hours, and lasts about 6–8 hours. It’s often administered 30 minutes before meals to cover post-meal blood sugar spikes. While effective, it has a slower onset and longer duration compared to rapid-acting insulins, so timing is crucial. It may be used alone or in combination with longer-acting insulins as part of a basal-bolus regimen.
Treatment Type: Prescription Medication
Treatment Class: Hormone
Treatment Modality: Injection, Intravenous (IV)
Review Summary
Based on the review, human regular insulin is an effective treatment for Type 1 Diabetes. It is a short-acting insulin used to manage blood sugar around meals, particularly as part of a basal-bolus insulin regimen. While it requires careful timing before eating and may be less convenient than newer insulin analogs, it remains a reliable and potentially more cost-effective option for managing Type 1 Diabetes.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
5.0
AI Summary of User Experiences
Not medical advice.
Based on the review, human regular insulin is an effective treatment for Type 1 Diabetes. It is a short-acting insulin used to manage blood sugar around meals, particularly as part of a basal-bolus insulin regimen. While it requires careful timing before eating and may be less convenient than newer insulin analogs, it remains a reliable and potentially more cost-effective option for managing Type 1 Diabetes.
Reviews
Filter by reviewer type Pro